The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Press release from PR Newswire

Boston Scientific to Announce Second-Quarter 2012 Financial Results on July 26

Thursday, July 12, 2012

Boston Scientific to Announce Second-Quarter 2012 Financial Results on July 2618:14 EDT Thursday, July 12, 2012NATICK, Mass., July 12, 2012 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will webcast its second-quarter 2012 financial results conference call on Thursday, July 26, at 8:00 a.m. Eastern Time.The call will be hosted by Hank Kucheman, chief executive officer, and Jeff Capello, executive vice president and chief financial officer.A live webcast of the conference call will be available via Boston Scientific's website.  Webcast registration is available on the Investor Relations section of the website at www.bostonscientific.com/investors.  Interested parties are encouraged to register at least 15 minutes prior to the scheduled start time to ensure a timely connection.The webcast is also being distributed over Thomson Reuters Investor Distribution Network via two locations: www.earnings.com, which is accessible to the public, and www.streetevents.com, a password-protected event management site.An archived replay of the webcast will be accessible at www.bostonscientific.com/investors approximately one hour following the completion of the conference call and available for approximately one year.The Company will issue a press release announcing second-quarter 2012 financial results prior to the conference call on Thursday, July 26.About Boston ScientificBoston Scientific is a worldwide developer, manufacturer and marketer of medical devices that are used in a broad range of interventional medical specialties.  For more information, please visit: www.bostonscientific.com.   CONTACT:    Steven Campanini508-652-5740 (office)Media RelationsBoston Scientific Corporationsteven.campanini@bsci.comSean Wirtjes508-652-5305 (office)Investor RelationsBoston Scientific CorporationInvestor_Relations@bsci.comSOURCE Boston Scientific Corporation